マイクロキャリアの市場規模・予測（2020年～2030年）、世界・地域シェア、動向、成長機会分析：製品別（培地・試薬、マイクロキャリアビーズ）、装置別（バイオリアクター、培養容器、その他）、用途別（バイオ医薬品製造、細胞・遺伝子治療、組織工学・再生医療、その他）、エンドユーザー（製薬・バイオテクノロジー企業、受託研究機関・受託製造機関、学術・研究機関）、地域別（北米、欧州、アジア太平洋、中東・アフリカ、中南米）

Microcarriers Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Product (Media and Reagents, and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

弊社の最新調査レポート「マイクロキャリア市場の2030年までの予測-世界分析-製品、装置、用途、エンドユーザー」によると、同市場は2022年の16億2500万米ドルから2030年には41億7800万米ドルに達すると予測され... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年11月7日	US$4,550 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	185	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

弊社の最新調査レポート「マイクロキャリア市場の2030年までの予測-世界分析-製品、装置、用途、エンドユーザー」によると、同市場は2022年の16億2500万米ドルから2030年には41億7800万米ドルに達すると予測されている。当レポートでは、市場を牽引する主な要因や著名なプレイヤーの動向を紹介しています。市場成長を促進する主な要因は、癌や感染症の罹患率上昇に伴う細胞療法の必要性、細胞・遺伝子治療製造のアウトソーシング人気の高まりである。しかし、生物製剤や細胞ベースの治療法はコストが高いため、市場成長の妨げとなっている。

マイクロキャリア市場で事業を展開する企業は、共同事業、事業拡大、契約、パートナーシップ、新製品発売などの戦略的展開に注力しており、売上の向上、地理的範囲の拡大、既存顧客ベースよりも多くの顧客に対応するための能力強化に貢献している。マイクロキャリア市場における注目すべき動向のいくつかを以下に挙げる：

- 2023年10月、株式会社クラレは再生医療で使用される細胞培養用のPVAハイドロゲルマイクロキャリアを開発した。2024年1月に国内、米国を皮切りに海外でも発売予定。

- 帝人フロンティアは2023年6月、スピーディーかつ大量・高品質な細胞培養を可能にする不織布マイクロキャリアを新発売した。この不織布マイクロキャリアは、帝人フロンティア独自の繊維プロセス技術や不織布設計技術、福井大学工学部による繊維関連のバイオメディカルノウハウを融合させたものである。

- 2023年10月、セマリオンはセマサイト・マイクロキャリア・プラットフォームのアーリー・アダプター・プログラムを発表した。セマリオンが開発したSemaCyteは、マイクロチップ製造技術、ナノ磁気、スマート材料を用いて作成された細胞キャリア材料である。このアッセイ用マイクロキャリアは平らで、超小型化された磁気的に操縦可能なウェルとして機能し、付着細胞の小さなコロニーを懸濁液に運び、細胞ベースの実験を改善する。

- 2022年1月、富士フイルムはAtara Biotherapeutics, Inc.から細胞治療製造施設を買収する計画を発表した。この施設は容易に拡張可能で、同種T細胞やCAR T免疫療法を含む臨床および商業用細胞療法を製造するための柔軟性がある。

- 2021年1月、サーモフィッシャーサイエンティフィック社は、ベルギーを拠点とするグループ・ノヴァセップSASのウイルスベクター製造事業であるHenogen S.A.を買収した。Henogen社はバイオテクノロジー企業や大手バイオ医薬品企業にワクチンや治療薬の製造サービスを提供している。この買収により、サーモフィッシャーサイエンティフィックは細胞・遺伝子ワクチンおよび治療薬カテゴリーにおける能力を拡大した。

したがって、PVAハイドロゲルマイクロキャリア、不織布マイクロキャリア、SemaCyteマイクロキャリアプラットフォームなどの製品を導入し、市場での競争力を維持するために提携やパートナーシップを通じて新規事業を開始することは、マイクロキャリア市場に大きな成長機会をもたらすだろう。

製品別に見ると、マイクロキャリア市場はマイクロキャリアビーズと培地・試薬に分けられる。2022年には、マイクロキャリアビーズセグメントが最大の市場シェアを占め、2022-2030年のCAGRは12.8%と最速を記録すると推定される。細胞生物学研究の拡大、再生医療やバイオ医薬品の需要、複数のメーカーやサプライヤーの存在が、市場の大幅な成長に寄与している。マイクロキャリア技術の広範な製品提供と継続的な開発は、主要市場プレーヤーの成長に有利な機会を提供している。ザルトリウスAGなどの主要企業は、動物性成分を含まず、タンパク質がコーティングされたマイクロキャリアビーズを提供している。

装置に基づいて、マイクロキャリア市場はバイオリアクター、培養容器、その他に区分される。2022年には、バイオリアクターセグメントが最大の市場シェアを占め、2022-2030年のCAGRは12.8%と最速を記録すると推定されている。バイオリアクターは、生物学的反応が行われる製造装置または容器であり、制御された条件下で適切な環境で酵母、細菌、動物細胞などの微生物を増殖させるために使用される。細胞の増殖や製品の形成に適した環境を維持する。マイクロキャリアベースのバイオリアクターは、細胞の成長と品質、代謝物の分析をリアルタイムでオフラインモニタリングすることができ、エラーを検出して直ちに修正するために活用することができる。

マイクロキャリア市場は用途別に、バイオ医薬品製造、細胞・遺伝子治療、組織工学・再生医療、その他に区分される。2022年には、バイオ医薬品生産分野が最大の市場シェアを占め、2022-2030年のCAGRは13.1%と最速を記録すると推定されている。バイオ医薬品生産セグメントは、さらに治療薬生産とワクチン生産に細分化される。マイクロキャリアはバイオ医薬品業界で確立された技術であり、攪拌槽型バイオリアクターと組み合わせることで、接着細胞の大量生産に必要な環境を提供できる。マイクロキャリアの製造に使用される生分解性材料は、in vitroでの疾患モデリングを解決する能力を持っている。マイクロキャリアは、制御可能な生分解のスペクトルを拡大することから、バイオ医薬品産業への応用が期待されている。

エンドユーザーに基づき、マイクロキャリア市場は製薬・バイオテクノロジー企業、受託研究機関および受託製造機関（CMO）、学術・研究機関に区分される。製薬・バイオテクノロジー企業セグメントが2022年の市場で最大のシェアを占めている。また、予測期間中の市場年平均成長率（CAGR）も12.9％と最も高いと推定されている。製薬会社は、医薬品製造全体の中で大きなシェアを占めている。医薬品製造プロセスは、多くの場合、インスリンやヒト成長ホルモンなどの製品を製造するために細菌を使用するバイオテクノロジーの原理に基づいている。医薬品・バイオテクノロジー産業は、主に研究開発活動の活発化と、微生物ベースの新製品導入のための規制当局の承認により、過去10年間で大きな成長を遂げた。このような大規模な技術革新は、今後数年間、製薬・バイオテクノロジー製造におけるバイオリアクターの採用を促進し、最終的には製薬・バイオテクノロジー分野のマイクロキャリア市場の成長に有利に働くと予測されている。

米国食品医薬品局（USFDA）、臨床経済審査研究所（ICER）、疾病管理予防センター（CDC）は、マイクロキャリア市場に関する報告書を作成する際に参照したいくつかの主要な一次および二次情報源です。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Microcarriers Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Microcarriers Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
5.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.2 Market Restraints
5.2.1 High Cost of Biologics and Cell-based Therapies
5.3 Market Opportunities
5.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
5.4 Future Trends
5.4.1 Automation of Cell and Gene Therapy Manufacturing Services
5.5 Impact Analysis
6. Microcarriers Market - Global Market Analysis
6.1 Microcarriers Market Revenue (US$ Mn), 2022 – 2030
7. Microcarriers Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Microcarrier Beads
7.3.1 Overview
7.3.2 Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Media and Reagents
7.4.1 Overview
7.4.2 Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8. Microcarriers Market – Revenue and Forecast to 2030 – by Equipment
8.1 Overview
8.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Bioreactors
8.3.1 Overview
8.3.2 Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Culture Vessels
8.4.1 Overview
8.4.2 Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9. Microcarriers Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Biopharmaceutical Production
9.3.1 Overview
9.3.2 Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.3.4 Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Cell and Gene Therapy
9.4.1 Overview
9.4.2 Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Tissue Engineering and Regenerative Medicine
9.5.1 Overview
9.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
10. Microcarriers Market Revenue and Forecasts To 2030 – End User
10.1 Overview
10.2 Global Microcarriers Market Share by End User - 2022 & 2030 (%)
10.3 Pharmaceutical and Biotechnology Companies
10.3.1 Overview
10.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market– Revenue and Forecast to 2030 (US$ Million)
10.4 Contract Research Organizations and Contract Manufacturing Organizations
10.4.1 Overview
10.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market– Revenue and Forecast to 2028 (US$ Million)
10.5 Academic and Research Institutes
10.5.1 Overview
10.5.2 Academic and Research Institutes: Microcarriers Market– Revenue and Forecast to 2028 (US$ Million)
11. Microcarriers Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 North America Microcarriers Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America: Microcarriers Market, by Product
11.1.4 North America: Microcarriers Market, by Equipment
11.1.5 North America: Microcarriers Market, by Application
11.1.5.1 North America: Microcarriers Market, by Biopharmaceutical Production
11.1.6 North America: Microcarriers Market, by End User
11.1.7 North America: Microcarriers Market, by Country
11.1.7.1 US
11.1.7.1.1 Overview
11.1.7.1.2 US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.1.3 US: Microcarriers Market, by Product
11.1.7.1.4 US: Microcarriers Market, by Equipment
11.1.7.1.5 US: Microcarriers Market, by Application
11.1.7.1.5.1 US: Microcarriers Market, by Biopharmaceutical Production
11.1.7.1.6 US: Microcarriers Market, by End User
11.1.7.2 Canada
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.2.3 Canada: Microcarriers Market, by Product
11.1.7.2.4 Canada: Microcarriers Market, by Equipment
11.1.7.2.5 Canada: Microcarriers Market, by Application
11.1.7.2.5.1 Canada: Microcarriers Market, by Biopharmaceutical Production
11.1.7.2.6 Canada: Microcarriers Market, by End User
11.1.7.3 Mexico
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.3.3 Mexico: Microcarriers Market, by Product
11.1.7.3.4 Mexico: Microcarriers Market, by Equipment
11.1.7.3.5 Mexico: Microcarriers Market, by Application
11.1.7.3.5.1 Mexico: Microcarriers Market, by Biopharmaceutical Production
11.1.7.3.6 Mexico: Microcarriers Market, by End User
11.2 Europe Microcarriers Market, Revenue and Forecast To 2030
11.2.1 Overview
11.2.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe: Microcarriers Market, by Product
11.2.4 Europe: Microcarriers Market, by Equipment
11.2.5 Europe: Microcarriers Market, by Application
11.2.5.1 Europe: Microcarriers Market, by Biopharmaceutical Production
11.2.6 Europe: Microcarriers Market, by End User
11.2.7 Europe: Microcarriers Market, by Country
11.2.7.1 Germany
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
11.2.7.1.3 Germany: Microcarriers Market, by Product
11.2.7.1.4 Germany: Microcarriers Market, by Equipment
11.2.7.1.5 Germany: Microcarriers Market, by Application
11.2.7.1.5.1 Germany: Microcarriers Market, by Biopharmaceutical Production
11.2.7.1.6 Germany: Microcarriers Market, by End User
11.2.7.2 UK
11.2.7.2.1 Overview
11.2.7.2.2 UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.2.3 UK: Microcarriers Market, by Product
11.2.7.2.4 UK: Microcarriers Market, by Equipment
11.2.7.2.5 UK: Microcarriers Market, by Application
11.2.7.2.5.1 UK: Microcarriers Market, by Biopharmaceutical Production
11.2.7.2.6 UK: Microcarriers Market, by End User
11.2.7.3 France
11.2.7.3.1 Overview
11.2.7.3.2 France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.3.3 France: Microcarriers Market, by Product
11.2.7.3.4 France: Microcarriers Market, by Equipment
11.2.7.3.5 France: Microcarriers Market, by Application
11.2.7.3.5.1 France: Microcarriers Market, by Biopharmaceutical Production
11.2.7.3.6 France: Microcarriers Market, by End User
11.2.7.4 Italy
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
11.2.7.4.3 Italy: Microcarriers Market, by Product
11.2.7.4.4 Italy: Microcarriers Market, by Equipment
11.2.7.4.5 Italy: Microcarriers Market, by Application
11.2.7.4.5.1 Italy: Microcarriers Market, by Biopharmaceutical Production
11.2.7.4.6 Italy: Microcarriers Market, by End User
11.2.7.5 Spain
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.5.3 Spain: Microcarriers Market, by Product
11.2.7.5.4 Spain: Microcarriers Market, by Equipment
11.2.7.5.5 Spain: Microcarriers Market, by Application
11.2.7.5.5.1 Spain: Microcarriers Market, by Biopharmaceutical Production
11.2.7.5.6 Spain: Microcarriers Market, by End User
11.2.7.6 Rest of Europe
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.6.3 Rest of Europe: Microcarriers Market, by Product
11.2.7.6.4 Rest of Europe: Microcarriers Market, by Equipment
11.2.7.6.5 Rest of Europe: Microcarriers Market, by Application
11.2.7.6.5.1 Rest of Europe: Microcarriers Market, by Biopharmaceutical Production
11.2.7.6.6 Rest of Europe: Microcarriers Market, by End User
11.3 Asia Pacific Microcarriers Market, Revenue and Forecast To 2030
11.3.1 Overview
11.3.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific: Microcarriers Market, by Product
11.3.4 Asia Pacific: Microcarriers Market, by Equipment
11.3.5 Asia Pacific: Microcarriers Market, by Application
11.3.5.1 Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
11.3.6 Asia Pacific: Microcarriers Market, by End User
11.3.7 Asia Pacific: Microcarriers Market, by Country
11.3.7.1 China
11.3.7.1.1 Overview
11.3.7.1.2 China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
11.3.7.1.3 China: Microcarriers Market, by Product
11.3.7.1.4 China: Microcarriers Market, by Equipment
11.3.7.1.5 China: Microcarriers Market, by Application
11.3.7.1.5.1 China: Microcarriers Market, by Biopharmaceutical Production
11.3.7.1.6 China: Microcarriers Market, by End User
11.3.7.2 Japan
11.3.7.2.1 Overview
11.3.7.2.2 Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.2.3 Japan: Microcarriers Market, by Product
11.3.7.2.4 Japan: Microcarriers Market, by Equipment
11.3.7.2.5 Japan: Microcarriers Market, by Application
11.3.7.2.5.1 Japan: Microcarriers Market, by Biopharmaceutical Production
11.3.7.2.6 Japan: Microcarriers Market, by End User
11.3.7.3 India
11.3.7.3.1 Overview
11.3.7.3.2 India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.3.3 India: Microcarriers Market, by Product
11.3.7.3.4 India: Microcarriers Market, by Equipment
11.3.7.3.5 India: Microcarriers Market, by Application
11.3.7.3.5.1 India: Microcarriers Market, by Biopharmaceutical Production
11.3.7.3.6 India: Microcarriers Market, by End User
11.3.7.4 Australia
11.3.7.4.1 Overview
11.3.7.4.2 Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
11.3.7.4.3 Australia: Microcarriers Market, by Product
11.3.7.4.4 Australia: Microcarriers Market, by Equipment
11.3.7.4.5 Australia: Microcarriers Market, by Application
11.3.7.4.5.1 Australia: Microcarriers Market, by Biopharmaceutical Production
11.3.7.4.6 Australia: Microcarriers Market, by End User
11.3.7.5 South Korea
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.5.3 South Korea: Microcarriers Market, by Product
11.3.7.5.4 South Korea: Microcarriers Market, by Equipment
11.3.7.5.5 South Korea: Microcarriers Market, by Application
11.3.7.5.5.1 South Korea: Microcarriers Market, by Biopharmaceutical Production
11.3.7.5.6 South Korea: Microcarriers Market, by End User
11.3.7.6 Rest of Asia Pacific
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.6.3 Rest of Asia Pacific: Microcarriers Market, by Product
11.3.7.6.4 Rest of Asia Pacific: Microcarriers Market, by Equipment
11.3.7.6.5 Rest of Asia Pacific: Microcarriers Market, by Application
11.3.7.6.5.1 Rest of Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
11.3.7.6.6 Rest of Asia Pacific: Microcarriers Market, by End User
11.4 Middle East & Africa Microcarriers Market, Revenue and Forecast To 2030
11.4.1 Overview
11.4.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa: Microcarriers Market, by Product
11.4.4 Middle East & Africa: Microcarriers Market, by Equipment
11.4.5 Middle East & Africa: Microcarriers Market, by Application
11.4.5.1 Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
11.4.6 Middle East & Africa: Microcarriers Market, by End User
11.4.7 Middle East & Africa: Microcarriers Market, by Country
11.4.7.1 Saudi Arabia
11.4.7.1.1 Overview
11.4.7.1.2 Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
11.4.7.1.3 Saudi Arabia: Microcarriers Market, by Product
11.4.7.1.4 Saudi Arabia: Microcarriers Market, by Equipment
11.4.7.1.5 Saudi Arabia: Microcarriers Market, by Application
11.4.7.1.5.1 Saudi Arabia: Microcarriers Market, by Biopharmaceutical Production
11.4.7.1.6 Saudi Arabia: Microcarriers Market, by End User
11.4.7.2 South Africa
11.4.7.2.1 Overview
11.4.7.2.2 South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.2.3 South Africa: Microcarriers Market, by Product
11.4.7.2.4 South Africa: Microcarriers Market, by Equipment
11.4.7.2.5 South Africa: Microcarriers Market, by Application
11.4.7.2.5.1 South Africa: Microcarriers Market, by Biopharmaceutical Production
11.4.7.2.6 South Africa: Microcarriers Market, by End User
11.4.7.3 UAE
11.4.7.3.1 Overview
11.4.7.3.2 UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.3.3 UAE: Microcarriers Market, by Product
11.4.7.3.4 UAE: Microcarriers Market, by Equipment
11.4.7.3.5 UAE: Microcarriers Market, by Application
11.4.7.3.5.1 UAE: Microcarriers Market, by Biopharmaceutical Production
11.4.7.3.6 UAE: Microcarriers Market, by End User
11.4.7.4 Rest Middle East & Africa
11.4.7.4.1 Overview
11.4.7.4.2 Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
11.4.7.4.3 Rest Middle East & Africa: Microcarriers Market, by Product
11.4.7.4.4 Rest Middle East & Africa: Microcarriers Market, by Equipment
11.4.7.4.5 Rest Middle East & Africa: Microcarriers Market, by Application
11.4.7.4.5.1 Rest Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
11.4.7.4.6 Rest Middle East & Africa: Microcarriers Market, by End User
11.5 South & Central America Microcarriers Market, Revenue and Forecast To 2030
11.5.1 Overview
11.5.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America: Microcarriers Market, by Product
11.5.4 South & Central America: Microcarriers Market, by Equipment
11.5.5 South & Central America: Microcarriers Market, by Application
11.5.5.1 South & Central America: Microcarriers Market, by Biopharmaceutical Production
11.5.6 South & Central America: Microcarriers Market, by End User
11.5.7 South & Central America: Microcarriers Market, by Country
11.5.7.1 Brazil
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
11.5.7.1.3 Brazil: Microcarriers Market, by Product
11.5.7.1.4 Brazil: Microcarriers Market, by Equipment
11.5.7.1.5 Brazil: Microcarriers Market, by Application
11.5.7.1.5.1 Brazil: Microcarriers Market, by Biopharmaceutical Production
11.5.7.1.6 Brazil: Microcarriers Market, by End User
11.5.7.2 Argentina
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.2.3 Argentina: Microcarriers Market, by Product
11.5.7.2.4 Argentina: Microcarriers Market, by Equipment
11.5.7.2.5 Argentina: Microcarriers Market, by Application
11.5.7.2.5.1 Argentina: Microcarriers Market, by Biopharmaceutical Production
11.5.7.2.6 Argentina: Microcarriers Market, by End User
11.5.7.3 Rest Of South & Central America
11.5.7.3.1 Overview
11.5.7.3.2 Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.3.3 Rest Of South & Central America: Microcarriers Market, by Product
11.5.7.3.4 Rest Of South & Central America: Microcarriers Market, by Equipment
11.5.7.3.5 Rest Of South & Central America: Microcarriers Market, by Application
11.5.7.3.5.1 Rest Of South & Central America: Microcarriers Market, by Biopharmaceutical Production
11.5.7.3.6 Rest Of South & Central America: Microcarriers Market, by End User
12. Microcarriers Market–Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Teijin Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bio-Rad Laboratories Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 denovoMATRIX GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sartorius AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Danaher Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Corning Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eppendorf SE
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Percell Biolytica AB
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Asahi Kasei Corp
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Polysciences Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

According to our latest study on "Microcarriers Market Forecast to 2030 – Global Analysis –Product, Equipment, Application, and End User," the market is expected to reach US$ 4.178 billion in 2030 from US$ 1.625 billion in 2022. The report highlights the key factors driving the market and prominent players with their developments. Key factors driving the market growth are need for cell therapies with rising incidence of cancer and infectious diseases, and increasing popularity of outsourcing cell and gene therapy manufacturing boost the market growth. However, the high cost of biologics and cell-based therapies hampers the market growth.

Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned below:

• In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US.

• In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier’s proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan.

• In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments.

• In January 2022, FUJIFILM Corporation announced its plan to acquire a cell therapy manufacturing facility from Atara Biotherapeutics, Inc. The facility is readily expandable and flexible to produce clinical and commercial cell therapies, including allogeneic T-cell and CAR T immunotherapies.

• In January 2021, Thermo Fisher Scientific Inc acquired Henogen S.A., a Belgium-based viral vector manufacturing business of Groupe Novasep SAS. Henogen provides vaccine and therapeutics manufacturing services to biotechnology companies and large biopharmaceutical customers. With this acquisition, Thermo Fisher Scientific expanded its capabilities in the cell and gene vaccines and therapies category.

Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.

Based on product, the microcarriers market is divided into microcarrier beads and media & reagents. In 2022, the microcarrier beads segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022–2030. Growing cell biology research, demand for regenerative medicines and biopharmaceuticals, and the presence of multiple manufacturers and suppliers contribute to the considerable market growth. Extensive product offerings and continuous developments in microcarrier technology offer lucrative opportunities for the growth of key market players. Major companies such as Sartorius AG offer microcarrier beads that are free of animal components and proteins coated.

Based on equipment, the microcarriers market is segmented into bioreactors, culture vessels, and others. In 2022, the bioreactors segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022–2030. Bioreactors are manufacturing devices or vessels in which biological reactions are carried out; they are used to grow microorganisms such as yeast, bacteria, or animal cells in an appropriate environment under controlled conditions. They maintain a supportable environment for cell growth and product formation. A microcarrier-based bioreactor allows real-time off-line monitoring of cell growth and quality and metabolite analyses, which can be utilised to detect errors and rectify them immediately.

Based on application, the microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and others. In 2022, the biopharmaceutical production segment held the largest market share, and same is estimated to register the fastest CAGR of 13.1% during 2022–2030. Biopharmaceutical production segment is further subsegmented into therapeutic production and vaccine production. Microcarriers are an established technology in the biopharmaceutical industry, which, in combination with stirred-tank bioreactors, can provide the necessary environment for large-scale production of adherent cells. Biodegradable materials used in the production of microcarriers have the capability to solve in vitro disease modeling. Microcarriers find applications in biopharmaceutical industries as they expand the spectrum of controllable biodegradation.

Based on end user, the microcarriers market is segmented pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations (CMOs), and academic and research institutes. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2022. Moreover, the same is estimated to register the highest CAGR of 12.9% in the market during the forecast period. Pharmaceutical companies hold a major share of the total medicine production. Pharmaceutical manufacturing processes are often based on biotechnology principles that involve the use of bacteria to produce insulin, human growth hormone, etc., products. The pharmaceutical and biotechnological industries have witnessed extensive growth in the past decade mainly owing to increased R&D activities and regulatory approvals for the introduction of new microbe-based products. Such a massive scale of innovation is projected to drive the adoption of bioreactors in pharmaceutical and biotechnological manufacturing in the coming years, eventually favoring the microcarriers market growth for the pharmaceutical and biotechnological segment.

United States Food and Drug Administration (USFDA), Institute for Clinical and Economic Review (ICER), Centers for Disease Control and Prevention (CDC), are a few key primary and secondary sources referred to while preparing the report on the microcarriers market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

The Insight Partners 社の最新刊レポート

本レポートと同じKEY WORD（asia pacific）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

The Insight Partners 社の最新刊レポート

本レポートと同じKEY WORD（asia pacific）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?